A carregar...


Regulatory Considerations for Gene Therapy Products in the US, EU, and Japan


Developers of gene therapy products (GTPs) must adhere to additional regulation beyond that of traditional small-molecule therapeutics, due to the unique mechanism-of-action of GTPs and the subsequent novel risks arisen. We have provided herein a summary of the regulatory structure under which GTPs...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Yale J Biol Med
Main Authors: Halioua-Haubold, Celine-Lea, Peyer, James G., Smith, James A., Arshad, Zeeshaan, Scholz, Matthew, Brindley, David A., MacLaren, Robert E.
Formato: Artigo
Idioma:Inglês
Publicado em: YJBM 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5733859/
https://ncbi.nlm.nih.gov/pubmed/29259533
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!